相关实验视频
Updated: Dec 3, 2025
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
13.2K
人类心脏衰竭中肌肉细胞基因表达特征
Virginia S Hahn1, Hildur Knutsdottir2, Xin Luo3
1Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD (V.S.H., J.V., D.A.K., K.S.).
Circulation
|October 29, 2020
概括
心脏衰竭与保存的喷射分数 (HFpEF) 具有独特的分子特征. 鉴别出不同的HFpEF小组, 揭示出这种具有挑战性的心脏病的潜在新治疗点.
科学领域:
- 心脏病学
- 分子生物学
- 基因组学
背景情况:
- 在所有心力衰竭病例中,心力衰竭与保留射出分数 (HFpEF) 占一半,但缺乏有效治疗方法.
- 对心脏组织的有限分子分析阻碍了对HFpEF心肌生物学的理解.
研究的目的:
- 对HFpEF患者的心脏组织进行全面的转录组分析.
- 确定HFpEF中的分子子组,并将其与临床和血液动力学数据相关联.
- 为了比较HFpEF与心力衰竭减少喷射分数 (HFrEF) 和健康对照的转录形状.
主要方法:
- 从HFpEF (n=41),HFrEF (n=30) 和供体对照进行了RNA测序.
- 使用主要成分分析和等级聚类来评估转录组的特异性和分离.
- 非负矩阵因子化和权重基因共表达网络分析确定了HFpEF中的分子子组.
主要成果:
- 转录组分析清楚地将HFpEF与HFrEF和对照物分开,即使对并发症进行了调整.
- 与对照组相比,HFpEF表现出独特的基因表达模式,包括上调的线粒体通路和下调的内质网膜应激/自通路.
- 确定了三个不同的HFpEF分子子组,与特定的临床特征和死亡风险相关.
结论:
- HFpEF具有独特的转录基因特征和与独特的临床特征和结果相关的分子分组.
- 这些发现突出了HFpEF中的新信号通路和分子子组,表明了精准医学的潜在目标.
相关概念视频
01:17Pathophysiology of Heart Failure
2.3K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.3K
01:29Heart Failure II: Pathophysiology
441
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
441
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
224
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
224
01:30Cardiomyopathy II: Dilated Cardiomyopathy
253
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
253
01:26Heart Failure III: Clinical Manifestations
272
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
272
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
286
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
286